BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.99 USD | +0.66% |
|
-1.92% | -14.27% |
| 01/05 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
| 01/05 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Other Pharmaceuticals | +0.66% | -1.92% | -14.27% | -34.17% | -9.52% | 89.17B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BMY Stock
- Charts Bristol-Myers Squibb Company
- Comparison Chart
